Gut Hormones and Weight: The Role of GLP-1, Insulin, and Leptin

Weight management is frequently framed as a behaviour challenge — a matter of discipline, food choices, and exercise habits. This framing is not wrong, but it is incomplete. Underneath every eating decision, every hunger pang, and every craving is a network of hormones that are actively regulating how hungry you feel, how efficiently your body stores energy, and how strongly your brain resists weight loss.

Understanding this hormonal system does not make weight management simple. But it does help explain why medical approaches to weight management exist as a distinct clinical category — and why they are meaningfully different from lifestyle-only programs. When the underlying hormonal signalling is disrupted, no amount of willpower fully compensates. The body is, in a very literal sense, working against itself.

This article covers the four key hormones involved in appetite and weight regulation — GLP-1, insulin, leptin, and ghrelin — and explains what the current science tells us about how they behave, how they interact, and why a thorough medical assessment considers this hormonal picture as part of evaluating each patient individually.

---

Why Hormones Are Central to Weight Regulation

The gut and the brain communicate constantly. This communication happens through a network of neural and hormonal signals — collectively referred to as the gut-brain axis — that govern hunger, satiety, energy storage, and metabolic rate. Appetite, in this context, is not a simple switch. It is the output of a complex signalling system that operates largely below conscious awareness.

This is why the popular directive to "eat less, move more" describes what needs to happen without explaining why it is often difficult to sustain. The hormonal system that regulates hunger can actively resist weight loss, increasing hunger signals and reducing satiety signals in response to a calorie deficit. This is not a failure of willpower. It is the body's adaptive response to perceived energy restriction — and it is mediated by hormones.

The four hormones most relevant to understanding weight regulation are:

Each of these hormones plays a distinct role. More importantly, they do not operate in isolation — they form a network in which a disruption in one system influences the others.

---

GLP-1 — The Satiety Signal From the Gut

What GLP-1 Is and Where It Comes From

GLP-1, or glucagon-like peptide-1, is an incretin hormone produced by specialised cells called L-cells, which line the small intestine and colon. It is released in response to food intake — particularly in response to nutrients entering the gut — and it plays a central role in coordinating the body's response to a meal.

GLP-1 is an endogenous hormone, meaning it is produced naturally by the body. Understanding its physiology helps explain why the hormonal dimension of weight regulation matters clinically.

What GLP-1 Does Physiologically

GLP-1 has several interconnected effects that collectively support satiety and glucose regulation:

• Slows gastric emptying — food moves more slowly from the stomach into the small intestine, which prolongs the physical sense of fullness after a meal
• Signals satiety to the brain — GLP-1 acts on receptors in the hypothalamus and brainstem, communicating that the body has received nutrition and reducing appetite signals
• Supports insulin secretion — GLP-1 acts on the pancreas to enhance the release of insulin in response to rising blood glucose, improving glucose disposal after meals
• Reduces glucagon secretion — by suppressing glucagon (which would otherwise raise blood glucose), GLP-1 helps moderate post-meal blood sugar rises

Blunted GLP-1 Response in Obesity

Research has identified that some individuals with obesity may have a blunted GLP-1 response — meaning the gut releases less of this hormone after eating, or the satiety signal it produces is diminished. This is a physiological finding, not a moral one. It helps explain, in part, why some people experience persistent hunger even after adequate meals and why the experience of weight management can differ so substantially between individuals.

This is exactly why a thorough clinical assessment considers the hormonal picture. A GP evaluating a patient's weight management needs is not simply counting calories or assessing willpower — they are assessing the full physiological context, including factors like hormonal signalling, that may be contributing to the patient's difficulty managing their weight. You can read more about how HPH approaches this clinical assessment at our medical weight loss program.

---

Insulin — More Than Blood Sugar

Insulin's Primary Role

Insulin is produced by beta cells in the pancreas and released in response to rising blood glucose — principally after meals. Its primary role is to facilitate the uptake of glucose into cells, where it can be used for energy. Without adequate insulin function, glucose accumulates in the bloodstream rather than being available to tissues.

Most people associate insulin with diabetes. But insulin is relevant to weight management well beyond the context of diabetes.

Insulin and Fat Storage

Insulin is a powerful regulator of fat metabolism. When circulating insulin levels are high, the body is in a state that promotes fat storage (lipogenesis) and inhibits fat breakdown (lipolysis). This is the body's normal response to eating — insulin rises after a meal, directing nutrients into storage.

The problem arises when insulin levels remain chronically elevated, as can occur with diets high in rapidly digested carbohydrates or in the context of insulin resistance. Persistently high insulin creates a metabolic environment that makes fat mobilisation physiologically difficult — not impossible, but working against the body's default signalling.

Insulin Resistance and Weight: The Chicken-and-Egg Problem

Insulin resistance — a state in which the body's cells respond less effectively to insulin's signalling — has a bidirectional relationship with excess weight. Visceral fat (fat stored around the organs) is metabolically active and contributes to insulin resistance. At the same time, insulin resistance promotes further fat accumulation, creating a reinforcing cycle.

This is why a medically supervised weight management program considers insulin sensitivity as part of the clinical picture — not just as a diabetes risk factor, but as a factor that directly influences the body's ability to respond to a calorie deficit. A GP reviewing baseline pathology, including fasting glucose and HbA1c, is assessing this dimension of the patient's metabolic health.

---

Leptin — The Satiety Hormone That Stops Working

What Leptin Is

Leptin is produced by adipose (fat) tissue and functions as a long-term energy signal to the brain. Unlike GLP-1, which signals satiety in the short-term context of a meal, leptin signals the brain about the body's overall energy stores. Higher levels of body fat lead to higher leptin production — in theory, telling the brain that energy stores are adequate and that appetite should be suppressed.

In theory.

Leptin Resistance: When the Signal Breaks Down

The paradox of leptin in obesity is that many individuals with excess weight have high circulating leptin — and yet remain hungry. This phenomenon is called leptin resistance, and it is one of the clearest examples of how the hormonal system can become dysregulated in ways that undermine self-directed weight management efforts.

In leptin resistance, the hypothalamus — the region of the brain that receives and acts on leptin signals — becomes desensitised to the hormone. The body is sending the "enough energy stored" signal, but the brain is not receiving it clearly. The result is persistent hunger and a drive to eat, even in the presence of adequate or excess energy stores.

Leptin resistance appears to be influenced by chronic inflammation, elevated triglycerides, and the same visceral fat accumulation that drives insulin resistance. The same metabolic picture that makes weight loss physiologically difficult also impairs the hormonal signals that should, in principle, make it easier.

Clinical Significance

Leptin resistance is a key reason that the "eat less, move more" directive — while directionally correct — does not adequately account for the biological complexity of weight management. A patient with leptin resistance is not simply choosing to ignore satiety signals. Those signals are genuinely impaired. This is a clinical matter, not a character one.

---

Ghrelin — The Hunger Hormone

What Ghrelin Does

Ghrelin is produced primarily in the stomach lining and is the body's principal hunger-stimulating hormone. Ghrelin levels rise before meals — triggering the sensation of hunger — and fall after eating. In this sense, it functions as the counterweight to satiety hormones like GLP-1 and leptin.

Ghrelin is also involved in sleep regulation, stress response, and reward signalling, which helps explain the links between poor sleep, stress, and increased appetite.

Ghrelin After Weight Loss

One of the most clinically significant findings in metabolic research is what happens to ghrelin levels after sustained weight loss: they rise. In other words, the body responds to weight loss by increasing its hunger signals. This is not a temporary adjustment — elevated ghrelin can persist for years following significant weight loss.

This physiological response is a major reason why maintaining weight loss is so difficult. The person who has successfully lost weight through a sustained calorie deficit may find themselves persistently hungry at a level that did not exist before — not because of reduced dietary discipline, but because their body is actively working to restore its previous energy stores.

Understanding ghrelin helps contextualise the high long-term relapse rates seen in lifestyle-only weight management programs. The hormonal system is not neutral — it has a set point it is working to restore, and it will use every available signal to do so.

---

How These Hormones Interact

GLP-1, insulin, leptin, and ghrelin do not operate as independent switches. They form an interconnected network in which each hormone influences the signalling environment for the others.

When leptin resistance develops, for example, the hypothalamus may become less responsive to satiety signals more broadly — including those sent by GLP-1. When insulin resistance is present, the metabolic environment promotes fat storage even during calorie restriction. When ghrelin levels are elevated following weight loss, the rising hunger signals can override GLP-1-mediated satiety.

The system is designed to maintain energy balance. In the context of excess weight and metabolic dysregulation, that design works against the goal of weight loss. Each disrupted signal compounds the others.

This is the biological basis for understanding why medically supervised approaches to weight management work with the hormonal system rather than against it. A clinical assessment that incorporates pathology review, metabolic markers, and individual history is assessing this hormonal picture as a whole — not simply evaluating calories in versus calories out. You can explore the clinical framework HPH uses in its structured programs at our protocols page.

---

What This Means for Medically Supervised Weight Management

The Medical Model Addresses Physiological Drivers

A GP-supervised weight management program considers far more than a patient's dietary habits. It looks at the metabolic and hormonal context: fasting glucose and HbA1c as markers of insulin sensitivity; lipid profile as an indicator of metabolic health; clinical history as a guide to what interventions have and have not worked.

This is meaningfully different from a calorie-counting app or a general dietitian referral, neither of which involves the clinical assessment of hormonal or metabolic factors, nor the ability to address those factors through prescription medicine where clinically appropriate.

Why Self-Directed Approaches Frequently Stall

The hormonal picture described in this article helps explain why highly motivated individuals often find weight management difficult to sustain without clinical support. When leptin resistance reduces the effectiveness of satiety signals, when ghrelin rises following weight loss, and when insulin resistance creates a metabolic environment that resists fat mobilisation, the challenge of maintaining a calorie deficit is genuinely physiological — not simply a matter of commitment.

This is not a reason to abandon self-directed lifestyle change. It is a reason to understand that for some patients, lifestyle change alone may not be sufficient to overcome the hormonal resistance the body mounts against weight loss. A clinical assessment can determine what additional support, if any, is appropriate for an individual's specific circumstances.

The Role of GP Assessment

What a GP assessment adds — beyond a general health check — is a structured evaluation of the individual's hormonal and metabolic picture. Blood work, clinical history, and a frank discussion about previous attempts and their outcomes provide the clinical foundation for understanding what kind of support is most likely to be effective for that individual.

The conclusion of that assessment is not a predetermined treatment. It is an informed, individualised clinical recommendation — which may include lifestyle-only support, referral to allied health, or prescription medicine, depending on the patient's clinical picture and goals.

If you are finding that self-directed weight management is not delivering the results you expect, or if you are curious about what the hormonal drivers of your experience might look like, speaking with a GP who specialises in metabolic health is the appropriate next step. An individual clinical assessment — not a self-assessment quiz or an online eligibility checker — is how this picture is properly evaluated.

---

Conclusion

The hormonal system that regulates appetite and weight is genuinely complex. GLP-1, insulin, leptin, and ghrelin each play distinct roles, and when one or more of these systems is dysregulated — through leptin resistance, blunted satiety signalling, insulin resistance, or elevated post-weight-loss ghrelin — weight management becomes a clinical issue as much as a behavioural one.

This is not a counsel of hopelessness. It is an argument for taking the biology seriously and seeking the right kind of support. A GP-supervised program assesses this full picture — the hormonal, metabolic, and individual clinical context — in a way that self-directed approaches cannot.

If you would like to understand more about how HPH approaches the clinical assessment of weight management, visit our medical weight loss program to learn about our GP-supervised program and discuss your individual circumstances with an HPH doctor.